Vitiligo Treatment Market to Hit USD 625.8 Million Mark by 2031 , Driven by Increasing Awareness about Vitiligo Among the General Population , Report
According to the report published by Allied Market Research, the global vitiligo treatment market was estimated at $410.5 million in 2021 and is expected to hit $625.8 million by 2031, registering a CAGR of 4.3% from 2022 to 2031.
๐น๐๐๐๐๐๐ ๐บ๐๐๐๐๐ ๐ช๐๐๐ ๐๐ ๐น๐๐๐๐๐-
https://www.alliedmarketresearch.com/request-sample/31914
Covid-19 scenario-
The global vitiligo treatment market experienced an initial downturn due to reduced demand for corticosteroids amidst the pandemic. Additionally, a significant portion of non-emergency medical services was postponed during this period. Nevertheless, the market has successfully rebounded and is now back on track.
In 2021, the corticosteroids segment dominated the global vitiligo treatment market, constituting over two-thirds of the market share, and is anticipated to maintain its leading position through 2031. This segment is projected to exhibit the highest compound annual growth rate (CAGR) of 4.7% from 2022 to 2031. The study also evaluates the calcineurin inhibitor segment.
Regional Analysis
In 2021, North America accounted for almost two-fifths of the total revenue in the global vitiligo treatment market and is expected to maintain its dominant position through 2031. Meanwhile, the Asia-Pacific region is projected to experience the highest compound annual growth rate (CAGR) of 5.4% during the forecast period. The report also analyzes other regions, including Europe and LAMEA.
๐ท๐๐๐๐๐๐ ๐ช๐๐๐๐๐๐๐ ๐น๐๐๐๐๐ (270 ๐ท๐๐๐๐ ๐ท๐ซ๐ญ ๐๐๐๐ ๐ฐ๐๐๐๐๐๐๐, ๐ช๐๐๐๐๐, ๐ป๐๐๐๐๐, ๐๐๐ ๐ญ๐๐๐๐๐๐) https://www.alliedmarketresearch.com/vitiligo-treatment-market/purchase-options
Vitiligo Treatment Market Report Highlights
AspectsDetailsMarket Size By 2031 | USD 625.8 million |
Growth Rate | CAGR of 4.3% |
Forecast period | 2021 โ 2031 |
Report Pages | 270 |
By Type |
|
By Distribution Channel |
|
By Drug Class Type |
|
By Region |
|
๐ฌ๐๐๐๐๐๐ ๐๐๐๐ ๐ฌ๐๐๐๐ ๐ซ๐๐๐๐ ๐ฏ๐๐๐: https://www.alliedmarketresearch.com/purchase-enquiry/31914
๐ด๐๐๐๐ ๐ฒ๐๐ ๐ฝ๐๐๐๐๐๐๐ ๐ป๐๐๐๐๐๐๐๐ ๐ด๐๐๐๐๐ ๐ท๐๐๐๐๐๐ โ
Glenmark Pharmaceuticals Ltd
Belcher Pharmaceuticals, LCC
Dr. Reddyโs Laboratories Ltd
Pfizer Inc.
Arcutis Biotherapeutics
Bausch Health Companies Inc.
Mylan N.V.
Celgene Corporation
Clinuvel Pharmaceuticals Ltd
Astellas Pharma Inc.
Panacea Biotec Ltd
Strides Pharma Science Limited
๐ฒ๐๐ ๐ฉ๐๐๐๐๐๐๐ ๐ญ๐๐ ๐บ๐๐๐๐๐๐๐๐
๐๐๐
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vitiligo treatment market analysis from 2021 to 2031 to identify the prevailing vitiligo treatment market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porterโs five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the vitiligo treatment market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global vitiligo treatment market trends, key players, market segments, application areas, and market growth strategies.
๐๐ญ๐ก๐๐ซ ๐๐ซ๐๐ง๐๐ข๐ง๐ ๐๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐ข๐ง ๐๐ข๐๐ ๐๐๐ข๐๐ง๐๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ-
Softgel Capsules Market https://www.alliedmarketresearch.com/softgel-capsules-market-A16306
Smart Medical Devices Market https://www.alliedmarketresearch.com/smart-medical-devices-market-A17644
Editor Details
-
Company:
- The Wire Times